- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00389142
Identifying Genetic Causes of IC/BPS
Genetic Studies in Interstitial Cystitis/Bladder Pain Syndrome/Chronic Pelvic Pain Syndrome (IC/BPS/CPPS)
Interstitial cystitis (IC), also called Bladder Pain syndrome (BPS), or chronic pelvic pain syndrome(CPPS) is a common condition with no known cause or cure. Twin studies and family accounts have suggested that the condition may be genetic or passed down (inherited) from one generation to another.
In this study, we are collecting genetic material and medical information from families in North America in an attempt to identify genetic factors that may cause IC/BPS/CPPS. We are enrolling families and individuals with IC/BPS/CPPS and their family members (both family members with and without IC like symptoms).
Study Overview
Status
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Pressley Smith, MS, LCGC
- Phone Number: 617-355-4764
- Email: Pressley.Smith@childrens.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Boston Children's Hospital (BCH)
-
Contact:
- Pressley Smith, BS
- Phone Number: 617-355-4764
- Email: pressley.smith@childrens.harvard.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of IC/BPS/CPPS
- Males and females of any age
- Urinary frequency - more than 1X/hour, and/or
- Dysuria, and/or
- Pelvic, suprapubic, or abdominal pain - for 3 months or longer
- Nocturia
- Normal urinary stream (by history)
- No evidence of active bacterial UTI (no pyuria & negative urinary culture for last 3 months)
- First degree relative of someone with above symptoms
Exclusion Criteria:
- Major structural/anatomical urinary tract abnormalities by ultrasound
- Underlying inborn conditions affecting the urinary tract
- Surgery/chemotherapy affected pelvic area
- GI or GU cancers
- Severe Constipation in children only
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
observational study
Time Frame: through study completion, average of 10 years
|
Outcome is candidate or causative genes for causing IC/BPS.
|
through study completion, average of 10 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Catherine Brownstein, Ph.D., Children's Hosptial, Boston
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 04-11-160
- 91208 (Other Grant/Funding Number: Broad Institute)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Interstitial Cystitis
-
Asan Medical CenterCompletedChronic Interstitial CystitisKorea, Republic of
-
St. Louis UniversityTerminated
-
St. Louis UniversityCompletedInterstitial Cystitis
-
Northwell HealthWithdrawnInterstitial CystitisUnited States
-
CAMC Health SystemCompletedInterstitial CystitisUnited States
-
UroGen Pharma Ltd.CompletedInterstitial Cystitis | ICIsrael
-
St. Louis UniversityCompleted
-
Drexel University College of MedicineMedtronicCompleted
-
AllerganTARIS Biomedical, Inc.TerminatedInterstitial CystitisUnited States, Canada